|
 |
|
 |
| "Restore stability of bones, Improves quality of Life " |
"The 1st and only bisphosphonate approved for the prevention of skeletal metastases associated with multiple myeloma and various solid tumours"
- Inhibit bone resorption and delays onset of skeletal complications.
- Safe and highly effective for long term therapy.
- More convienient to administer than other i.v bisphosphonates.
|
| Composition |
| Each ml of sterile solution contains: |
| Zoledronic acid 4mg |
|
| |
| Strength/Packing |
| Each combipack contains |
| One vial of : |
| Zoledronic Acid Monohydrate 4.264mg (Equivalent to Zoledronic Acid anhydrous 4mg) |
| Mannitol USP (in lyophilized form) 220 mg |
| And One ampule containing : |
| Sterile water for injection I.P 5ml |
|
|
